Year |
Citation |
Score |
2019 |
Mixson AJ, Leng Q, Chou ST, Woodle MC. Targeting Cancer with Peptide RNAi Nanoplexes. Methods in Molecular Biology (Clifton, N.J.). 1974: 161-180. PMID 31099002 DOI: 10.1007/978-1-4939-9220-1_12 |
0.679 |
|
2016 |
Chou ST, Patil R, Galstyan A, Gangalum PR, Cavenee WK, Furnari FB, Ljubimov VA, Chesnokova A, Kramerov AA, Ding H, Falahatian V, Mashouf L, Fox I, Black KL, Holler E, et al. Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27825958 DOI: 10.1016/J.Jconrel.2016.11.001 |
0.359 |
|
2014 |
Chou ST, Mixson AJ. siRNA nanoparticles: the future of RNAi therapeutics for oncology? Nanomedicine (London, England). 9: 2251-4. PMID 25413851 DOI: 10.2217/Nnm.14.157 |
0.631 |
|
2014 |
Leng Q, Chou ST, Scaria PV, Woodle MC, Mixson AJ. Increased tumor distribution and expression of histidine-rich plasmid polyplexes. The Journal of Gene Medicine. 16: 317-28. PMID 25303767 DOI: 10.1002/Jgm.2807 |
0.646 |
|
2014 |
Lee A, Karcz A, Akman R, Zheng T, Kwon S, Chou ST, Sucayan S, Tricoli LJ, Hustedt JM, Leng Q, Kahn JD, Mixson AJ, Seog J. Direct observation of dynamic mechanical regulation of DNA condensation by environmental stimuli. Angewandte Chemie (International Ed. in English). 53: 10631-5. PMID 25146232 DOI: 10.1002/Anie.201403499 |
0.618 |
|
2014 |
Scaria PV, Liu Y, Leng Q, Chou ST, Mixson AJ, Woodle MC. Enhancement of antifungal activity by integrin-targeting of branched histidine rich peptides. Journal of Drug Targeting. 22: 536-42. PMID 24731059 DOI: 10.3109/1061186X.2014.905948 |
0.67 |
|
2014 |
Chou ST, Hom K, Zhang D, Leng Q, Tricoli LJ, Hustedt JM, Lee A, Shapiro MJ, Seog J, Kahn JD, Mixson AJ. Enhanced silencing and stabilization of siRNA polyplexes by histidine-mediated hydrogen bonds. Biomaterials. 35: 846-55. PMID 24161165 DOI: 10.1016/J.Biomaterials.2013.10.019 |
0.648 |
|
2013 |
Chou ST, Leng Q, Scaria P, Kahn JD, Tricoli LJ, Woodle M, Mixson AJ. Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition. Biomacromolecules. 14: 752-60. PMID 23360232 DOI: 10.1021/Bm3018356 |
0.646 |
|
2012 |
Chou ST, Leng Q, Mixson AJ. Zinc Finger Nucleases: Tailor-made for Gene Therapy. Drugs of the Future. 37: 183-196. PMID 24155503 DOI: 10.1358/Dof.2012.037.03.1779022 |
0.604 |
|
2012 |
Leng Q, Chou ST, Scaria PV, Woodle MC, Mixson AJ. Buffering capacity and size of siRNA polyplexes influence cytokine levels. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 2282-90. PMID 23032972 DOI: 10.1038/Mt.2012.206 |
0.663 |
|
2011 |
Chou ST, Leng Q, Scaria P, Woodle M, Mixson AJ. Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo. Cancer Gene Therapy. 18: 707-16. PMID 21818135 DOI: 10.1038/cgt.2011.40 |
0.658 |
|
2011 |
Matejuk A, Leng Q, Chou ST, Mixson AJ. Vaccines targeting the neovasculature of tumors. Vascular Cell. 3: 7. PMID 21385454 DOI: 10.1186/2045-824X-3-7 |
0.623 |
|
2010 |
Matejuk A, Leng Q, Begum MD, Woodle MC, Scaria P, Chou ST, Mixson AJ. Peptide-based Antifungal Therapies against Emerging Infections. Drugs of the Future. 35: 197. PMID 20495663 DOI: 10.1358/Dof.2010.035.03.1452077 |
0.636 |
|
Show low-probability matches. |